HBsAg Kinetics in Retreatment Decision for Off-Therapy Hepatitis B Flare in HBeAg- Negative Patients Yun-Fan Liaw, Wen-Juei Jeng, Ming-Ling Chang Gastroenterology Volume 154, Issue 8, Pages 2280-2281 (June 2018) DOI: 10.1053/j.gastro.2018.03.066 Copyright © 2018 AGA Institute Terms and Conditions
Figure 1 The clinical course in 2 hepatitis B e antigen (HBeAg)-negative patients with hepatitis B flare after end of antiviral therapy (EOT). (A) No retreatment is needed in patients with successive HBsAg decline, whereas (B) retreatment is required in patient with increasing HBsAg levels. The horizontal dotted line indicates the upper limit normal of alanine aminotransferase (ALT; 36 U/L). Gastroenterology 2018 154, 2280-2281DOI: (10.1053/j.gastro.2018.03.066) Copyright © 2018 AGA Institute Terms and Conditions